LINC01116对患者生存的影响不同,并且在ER+和ER-乳腺癌样本中表达不一样
Mohammadjavad Karimi Taheri1, Sogol Ghanbari1, Akram Gholipour2
1Molecular Genetics Department, Biological Sciences Faculty, Tarbiat Modares University, Tehran, Iran.
Cancer reports (Hoboken, N.J.)
|June 15, 2023
概括
长非编码RNA LINC01116 在乳腺癌中被上调,特别是在ER+组织中. 它的表达根据雌激素受体状态不同地影响患者的生存,这表明它是一种潜在的生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 乳腺癌是全球癌症死亡的主要原因之一.
- 长非编码RNAs (lncRNAs) 的异常表达与瘤的进展和发展有关.
研究的目的:
- 为了评估LINC01116在乳腺癌组织中的表达模式.
- 调查LINC01116对乳腺癌患者存活率的影响.
- 探索LINC01116在雌激素受体阳性 (ER+) 和雌激素受体阴性 (ER-) 乳腺癌中的作用.
主要方法:
- 对微阵列和qRT-PCR数据的分析.
- 使用KM-plotter数据库进行生存分析.
- 在乳腺癌细胞系中使用了体外功能增益测试.
主要成果:
- 与ER-组织相比,LINC01116在ER+瘤组织中显著上调.
- 与正常组织相比,LINC01116表达在ER+瘤组织中增加,在ER-瘤组织中减少.
- 在所有和ER+患者中,LINC01116与存活率呈正相关性,但在ER-患者中呈负相关性.
- 过度表达LINC01116诱导了ER细胞中的TGF-β信号传递,并且在接受17β- Estradiol治疗的MCF7细胞中被上调.
结论:
- LINC01116作为一种潜在的生物标志物,用于区分ER+和ER-乳腺癌组织.
- 根据ER状态,LINC01116对患者的生存有不同的影响.
- LINC01116通过调节TGF-β和雌激素受体信号通路来影响患者的结果.
相关概念视频
Non-LTR Retrotransposons
11.6K
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
11.6K
lncRNA - Long Non-coding RNAs
8.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.7K


